Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | +1.16% | -0.57% | +19.05% |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.05% | 94.27M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.80% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |
- Stock
- Equities
- Stock Spero Therapeutics, Inc. - Nasdaq
- News Spero Therapeutics, Inc.
- Evercore ISI Upgrades Spero Therapeutics to Outperform From In-Line